Description
A benzylisoquinoline that acts as a neuromuscular blocking agent with slow onset and intermediate duration; causes non-depolarizing block of the neuromuscular junction
Formal name: 2,2’-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium, dibenzenesulfonate
Synonyms: BW 33A|Tracrium|Wellcome 33A74
Molecular weight: 1,243.50
CAS: 64228-81-5
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Neuroscience